NCT02995304

Brief Summary

In this double blind study, after taking an informed consent, 60 children aged between 7 and 12 years old assigned for tonsillectomy with or without adenoidectomy will be randomly divided into three groups. The first group 30 children will receive 0.025 mg/kg midazolam IV followed by 0.1 mg/kg morphine as a premedication 20 to 30 min before surgical incision. In the second group30 children who will receive the same dose of midazolam followed by saline premedication. All groups will be compared for pain score using visual analog scale (VAS) after recovery and hourly for 8 hours and during first drinking. Heart rate (HR), blood pressure and peripheral oxygen saturation (SPO2) will be recorded before premedication, every 10 min after premedication then every 5 min during and after anesthesia. 6 point sedation score and 4 points behavioral score will be monitored every 5 min after sedation. Four-point wake-up score will be recorded every 5 min. Time of first analgesic requirement and total morphine consumption during the first post-operative 8 hours will be recorded.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2016

Completed
29 days until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 16, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Last Updated

December 16, 2016

Status Verified

December 1, 2016

Enrollment Period

3 months

First QC Date

November 2, 2016

Last Update Submit

December 13, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative morphine requirement

    8 hours

Secondary Outcomes (3)

  • Postoperative nonsteroidal analgesic requirements

    two days

  • Preoperative behavior score

    15 to 30 minutes

  • Wake-up behavior scores

    30 minutes

Study Arms (2)

Morphine and Midazolam premedication

ACTIVE COMPARATOR

30 children will receive 0.025 mg/kg midazolam IV followed by 0.1 mg/kg morphine 20 to 30 min before surgical incision.

Drug: Morphine premedicationDrug: Midazolam premedication

Midazolam only premedication

ACTIVE COMPARATOR

30 children who will receive 0.025 mg/kg midazolam IV followed by saline 20 to 30 min before surgical incision.

Drug: Midazolam premedicationDrug: Saline premedication (placebo)

Interventions

30 children will 0.1 mg/kg morphine as a premedication 20 to 30 min before surgical incision.

Morphine and Midazolam premedication

All children who will receive 0.025 mg/kg midazolam IV as a premedication 20 to 30 min before surgical incision.

Midazolam only premedicationMorphine and Midazolam premedication

30 children in midazolam only group will receive saline after midazolam

Midazolam only premedication

Eligibility Criteria

Age7 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Tonsillectomy procedures in
  • Children aged between 7 and 12 years old.

You may not qualify if:

  • Bronchial asthma, obstructive sleep apnea, allergy to medications used in the study and those who are unfit for surgery or anesthesia for any reason like coagulopathy or chest infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Doctor Soliman Fakeeh Hospital

Jeddah, 21461, Saudi Arabia

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Amr A Keera, MD

    Doctor Soliman Fakeeh Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amr A Keera, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

November 2, 2016

First Posted

December 16, 2016

Study Start

December 1, 2016

Primary Completion

March 1, 2017

Last Updated

December 16, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations